AKT1 and rheumatoid arthritis: And we identified the ICOS ligand (ICOSL) of UC‐MSCs combined with ICOS of RA patients, activating Phosphatidylinositol 3‐kinase / Protein kinase B / Mammalian target of rapamycin (PI3K/AKT/mTOR).